SEC Comment Letter for VioQuest Pharmaceuticals, Inc. (CIK 0000745788) — Oct 5, 2005

VioQuest Pharmaceuticals, Inc. (CIK 0000745788)
Date: Oct. 5, 2005 · CIK: 0000745788 · Accession: 0000000000-05-051387

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 000-16686

Date

August 8, 2005

Author

Jim Atkinson

Form

UPLOAD

Company

VioQuest Pharmaceuticals, Inc. (CIK 0000745788)

Letter

Via Facsimile and U.S. Mail Mail Stop 6010 August 8, 2005 Mr. Brian Lenz Chief Financial Officer and Secretary VioQuest Pharmaceuticals, Inc. 7 Deer Park Drive, Suite E Princeton Corporate Plaza Monmouth Junction, NJ 08852

Re: VioQuest Pharmaceuticals, Inc. Form 10-KSB for the fiscal year ended December 31, 2004 Filed on March 31, 2005 File No. 000-16686

Dear Mr. Lenz:

We have completed our review of your Form 10-KSB and have no further comments at this time.

Sincerely,
Jim Atkinson
Accounting Branch Chief

Show Raw Text

<DOCUMENT>
<TYPE>LETTER
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>

Via Facsimile and U.S. Mail
Mail Stop 6010

August 8, 2005

Mr. Brian Lenz
Chief Financial Officer and Secretary
VioQuest Pharmaceuticals, Inc.
7 Deer Park Drive, Suite E
Princeton Corporate Plaza
Monmouth Junction, NJ  08852

Re:	VioQuest Pharmaceuticals, Inc.
	Form 10-KSB for the fiscal year ended December 31, 2004
	Filed on March 31, 2005
	File No. 000-16686

Dear Mr. Lenz:

	We have completed our review of your Form 10-KSB and have no
further comments at this time.

								Sincerely,

								Jim Atkinson
      Accounting Branch Chief

</TEXT>
</DOCUMENT>

SecProbe.io